Key facts
- Notable investors include Hangzhou Capital, Huakong Electronics (Tianjin) Investment Management, JHT Asset Management, Xihu VC, Z&H Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Jlife Technology (Hangzhou)
- ·The full record, as it builds
Funding rounds
No funding rounds for Jlife Technology (Hangzhou) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jlife Technology (Hangzhou)
Developer of a scientific technology platform designed to enhance life sciences research and intelligent manufacturing. The company offers expertise in specialized equipment development, advanced software, and collaborative research, enabling technology-driven enterprises, research institutions, and industrial clients to achieve enhanced productivity, technical excellence, and sustained growth.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Jlife Technology (Hangzhou) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jlife Technology (Hangzhou) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jlife Technology (Hangzhou) in its N-PORT filings yet. We sweep new filings monthly.